Literature DB >> 1701800

Induction of human T cell proliferation by a monoclonal antibody to CD5.

F Spertini1, W Stohl, N Ramesh, C Moody, R S Geha.   

Abstract

A mouse mAb, TS 43, which recognized the human CD5 molecule, was found to induce the proliferation of human peripheral blood T cells. TS 43 mAb precipitated from 125I-radiolabeled T cells a 67-kDa band, which comigrated with the 67-kDa band precipitated by the anti-CD5 mAb OKT1. Preclearing of cell lysates with OKT1 mAb abolished the capacity of TS 43 mAb to precipitate radiolabeled material from T cell lysates. Furthermore, a mouse T cell hybridoma transfected with human CD5 was stained by TS 43 mAb. T cell proliferation mediated by TS 43 mAb was monocyte dependent, and was accompanied by IL-2R expression and by IL-2 synthesis. T cell activation by TS 43 mAb involved a rise in intracellular calcium level (CA2+)i and was dependent on the expression of the TCR/CD3 complex because no rise in (Ca2+)i was observed in a TCR-beta-deficient Jurkat T cell mutant. This study indicates that CD5 should be added to the list of surface molecules that can signal T cells to proliferate.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1701800

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1.

Authors:  J J Perez-Villar; G S Whitney; M A Bowen; D H Hewgill; A A Aruffo; S B Kanner
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  Isolation and nucleotide sequence of sheep CD5.

Authors:  S A Fabb; K J Gogolin-Ewens; J F Maddox
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

3.  Evidence for a trans-acting activator function regulating the expression of the human CD5 antigen.

Authors:  M T Scupoli; S Sartoris; M Nicolis; T Cestari; C Cambiaggi; G Tridente; R S Accolla
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

4.  Molecular linkage of the mouse CD5 and CD6 genes.

Authors:  O Lecomte; J B Bock; B W Birren; D Vollrath; J R Parnes
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

5.  Signaling through CD5 activates a pathway involving phosphatidylinositol 3-kinase, Vav, and Rac1 in human mature T lymphocytes.

Authors:  S I Gringhuis; L F de Leij; P J Coffer; E Vellenga
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

6.  Expression of CD5 and CD72 on T and B cell subsets in rheumatoid arthritis and Sjögren's syndrome.

Authors:  C Jamin; A Lamour; Y L Pennec; M Hirn; P Le Goff; P Youinou
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

7.  CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn.

Authors:  K E Burgess; M Yamamoto; K V Prasad; C E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

8.  CD5 is phosphorylated on tyrosine after stimulation of the T-cell antigen receptor complex.

Authors:  A A Davies; S C Ley; M J Crumpton
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

9.  Dynamics of CD4(+) T cell responses against Listeria monocytogenes.

Authors:  Frederik Graw; K Scott Weber; Paul M Allen; Alan S Perelson
Journal:  J Immunol       Date:  2012-10-24       Impact factor: 5.422

10.  CD5 expression in thymic carcinoma.

Authors:  T Hishima; M Fukayama; M Fujisawa; Y Hayashi; K Arai; N Funata; M Koike
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.